Menopause after hysterectomy

Key takeaways

• Not every hysterectomy causes menopause. Whether your ovaries were removed determines what happens to your hormones and how quickly symptoms arrive.
• Surgical menopause, where both ovaries are removed before natural menopause age, tends to produce more abrupt and more severe symptoms than natural menopause, and carries long term health implications for bone, heart, and cognitive health that make proper HRT management genuinely important.
• Women who have had a total hysterectomy are sometimes offered oestrogen only HRT rather than combined HRT, because there is no uterine lining left to protect.There are some cases where progesterone is recommended, such as in the case of extensive endometriosis after hysterectomy.

A hysterectomy is one of the most commonly performed gynaecological surgeries in the UK, and yet many women come out of it with very little clarity about what it means for their hormones, their symptoms, and their long term health. The answer depends significantly on what type of hysterectomy was performed, and whether the ovaries were removed alongside the uterus.

This article covers the key distinctions, what the evidence says about managing symptoms, why surgical menopause carries specific long term health considerations that natural menopause does not, and what UK clinical guidance recommends for HRT in this context. It references NICE guideline NG23 throughout and is written specifically for a UK audience.

Does a hysterectomy always cause menopause?

No, the uterus is not the source of the hormones that regulate menopause. The ovaries are. A hysterectomy removes the uterus, which means periods stop immediately. But if the ovaries are left in place, they continue producing oestrogen and progesterone, and the transition to menopause happens naturally in its own time, typically around the average age of 51 in the UK. The removal of the uterus may, in some women, lead to slightly earlier natural menopause due to changes in blood supply to the ovaries, but this is not the same as surgical menopause and the effect is modest.

Menopause caused by a hysterectomy is therefore specifically a result of ovary removal, not the surgery itself.

The two paths: hysterectomy with or without ovary removal

The clinical distinction that matters most is whether a bilateral oophorectomy (removal of both ovaries) was performed alongside the hysterectomy.

Hysterectomy without oophorectomy. The ovaries remain and continue producing hormones. Periods stop because the uterus has been removed, but the hormonal pattern of the menstrual cycle continues until natural menopause arrives. Women in this group may still experience menopause symptoms eventually, but the transition is gradual and occurs at around the natural age.

Hysterectomy with bilateral oophorectomy (also called bilateral salpingo-oophorectomy when the fallopian tubes are removed at the same time). Both ovaries are removed and oestrogen production drops sharply and immediately. This is surgical menopause, also known by some as “crash menopause,” and it is fundamentally different from natural menopause in its speed, severity, and long term implications. A comprehensive review published in Women's Health (Parker et al., 2009) found premenopausal bilateral oophorectomy to be associated with significantly elevated risks across multiple health domains when not followed by appropriate hormonal management.

What is surgical menopause, and how is it different from natural menopause?

Natural menopause is a gradual process. Oestrogen levels decline over several years, the body adapts incrementally, and perimenopause provides a kind of hormonal runway before the final transition.

Surgical menopause removes that runway entirely. When both ovaries are removed, oestrogen drops to very low levels within hours of the procedure. There is no perimenopause. There is no adjustment period. The result is that symptoms frequently arrive sooner, more intensely, and more suddenly than they would through natural hormonal decline.

A comprehensive update review published in Climacteric (Rocca et al., 2021) from the research group that has produced the most rigorous long term evidence on this topic describes the consequences of premature or early bilateral oophorectomy across cardiovascular, cognitive, musculoskeletal, and neurological domains. Their conclusion: HRT initiated promptly after surgery substantially reduces these risks, particularly when continued until at least the natural age of menopause.

This is not a reason to be frightened of a hysterectomy that was medically necessary. It is a reason to take the hormonal management that follows it seriously.

Symptoms to expect after a hysterectomy

For women who had an ovary-conserving hysterectomy, the eventual symptoms of natural menopause will arrive in the same way they would have otherwise. There may be some mild disruption in the months following surgery, but the hormonal picture remains broadly intact.

For women who underwent bilateral oophorectomy, symptoms can begin within days of surgery.

The most common include:

• Hot flushes and night sweats
• Sleep disruption
• Low mood, irritability, or anxiety
• Brain fog and difficulty concentrating
• Vaginal dryness and discomfort
• Reduced libido
• Joint pain and fatigue

The abruptness of onset is what many women find most difficult. Symptoms that might have developed gradually over several years of perimenopause instead arrive all at once. A prospective study published in the European Journal of Cancer (Vermeulen et al., 2017) found that HRT after bilateral oophorectomy significantly reduced vasomotor, urogenital, and sexual symptoms. This study was conducted in women undergoing risk-reducing surgery rather than the full range of hysterectomy patients, so the findings should be understood as directionally applicable rather than universally representative.

Without treatment, these symptoms do not necessarily resolve quickly. They persist until the body's oestrogen levels reach the low point that would eventually be reached after natural menopause, which can take considerably longer when surgery occurs well before the natural menopause age.

How do you know you're in menopause without periods to guide you?

This is one of the practical challenges specific to women who have had a hysterectomy. The usual marker of menopause, twelve months without a period, is no longer available. For women who have had a bilateral oophorectomy, the absence of periods combined with the abrupt onset of symptoms is usually sufficient to establish that surgical menopause has occurred. There is no ambiguity in most cases.

For women who retained their ovaries after a hysterectomy, understanding when natural menopause arrives is more challenging. Symptoms such as hot flushes, sleep disruption, and mood changes provide the primary signals.

NICE guideline NG23 is clear that for women aged 45 and over with menopausal symptoms, clinical assessment of those symptoms is the primary diagnostic tool. A specialist may use an FSH (follicle stimulating hormone) blood test in specific circumstances, particularly for women under 45 where early or premature menopause is suspected, but FSH testing is not routinely indicated for women over 45 as a diagnostic step. If you are unsure whether you are in menopause, a specialist consultation focused on your symptoms and history is the appropriate starting point.

The long term health picture: why surgical menopause matters beyond symptoms

This is the section that is missing from every article currently ranking for this keyword, and it is the most clinically important. Oestrogen does more than regulate the menstrual cycle and manage hot flushes. It plays a protective role across multiple body systems, and when it is removed abruptly before natural menopause age, the consequences extend well beyond symptom management.

Cognitive health. A large study published in JAMA Network Open (Rocca et al., 2021) involving data from 2,732 women found that premenopausal bilateral oophorectomy was associated with increased risk of mild cognitive impairment, with greater risk at younger ages at surgery. Earlier foundational work published in Neurology (Rocca et al., 2007) established a significantly increased risk of cognitive impairment or dementia in women who underwent oophorectomy before natural menopause. These findings should be understood as risk associations, not certainties for any individual woman. Research in this area continues to develop.

Cardiovascular health. Research published in Menopause (Shoupe et al., 2007) found that women who underwent bilateral oophorectomy before age 45 had significantly increased cardiovascular mortality compared to referent women. Critically, this increased risk was not seen in women who used post-surgical oestrogen. This is observational evidence and cannot establish causation definitively, but it is consistent with the broader literature on oestrogen's cardiovascular role.

Bone health. Oestrogen plays a central role in maintaining bone density. Early oestrogen loss is associated with accelerated bone loss and increased fracture risk. The Rocca et al. 2021 Climacteric review identifies musculoskeletal health as one of the domains most clearly affected by premature oophorectomy.

"The purpose of this evidence is not to cause alarm. It is to make clear why getting the right hormonal support promptly after a hysterectomy with oophorectomy is not just about managing hot flushes. It is about long term health in a meaningful sense, and it is exactly the kind of picture that a specialist consultation, rather than a brief post-operative appointment, is equipped to address.”

Katy Jackson, Clinical Director - Women's Health

HRT after a hysterectomy: what type, and why it is different

Women who have had a total hysterectomy are typically offered oestrogen only HRT rather than combined HRT (oestrogen plus progestogen). The reason is straightforward: progestogen in combined HRT is included to protect the uterine lining from oestrogen stimulation. Without a uterus, that protection is not needed.

NICE guideline NG23 explicitly recommends offering oestrogen only HRT to people who have had a total hysterectomy. Oestrogen only HRT is associated with a more favourable risk profile than combined HRT in several respects, which is a meaningful consideration for women who may need to take HRT for a longer period following early surgical menopause.

There is an important exception. Women who had a hysterectomy due to endometriosis may still have endometrial deposits in other pelvic locations, which oestrogen can stimulate. For these women, a specialist may recommend adding progestogen even after hysterectomy. This is a clinical conversation specific to individual history, not a generalised recommendation, and it underscores why specialist input matters rather than assuming a standard protocol applies. Menopause specialists may consider using progesterone on an individualised basis depending on symptoms.

Testosterone is also worth raising with your specialist. Often associated with men, testosterone is equally important for women's energy, mood, and libido, and is produced in women from their ovaries and adrenal glands. After bilateral oophorectomy, testosterone levels fall alongside oestrogen, and for women experiencing persistent low libido, fatigue, or low mood despite oestrogen therapy, a testosterone assessment may be appropriate. Your specialist can advise and, where needed, arrange the relevant blood test.

Women who had a hysterectomy for cancer should discuss HRT with a specialist who can assess suitability based on cancer type, staging, and individual history. Guidance differs across cancer types and this article does not attempt to specify it. Specialist input is essential in this group.

How long should you take HRT after a hysterectomy?

This is one of the most frequently misunderstood aspects of post-hysterectomy care, and it is absent from all three of the most commonly found articles on this topic.

For women who have undergone surgical menopause before the natural age of menopause (on average around 51 in the UK), NICE guideline NG23 recommends that HRT should continue until at least the natural age of menopause. The reasoning is the long term health evidence set out above. Taking HRT until the age of 51 in a woman whose ovaries were removed at 38 is not prolonged HRT use in the risk sense it might be for a woman starting HRT at 55. It is replacing hormones that would naturally have been present until around that age.

After the natural menopause age, the question of whether to continue HRT is a separate individual benefit and risk discussion, as it would be for any woman starting HRT around natural menopause timing. The Rocca et al. Climacteric 2021 review concludes that HRT initiated promptly and continued appropriately substantially reduces the long term risks associated with premature oophorectomy.

Managing symptoms without HRT, or alongside it

HRT is the most effective treatment for surgical menopause symptoms, but it is not the only option available, and for some women it may not be appropriate depending on medical history.

NICE NG23 recognises CBT (Cognitive Behavioural Therapy: a structured talking therapy) as an evidence based option for psychological menopause symptoms and, in its 2024 update, for vasomotor symptoms including hot flushes. For women with surgical menopause experiencing anxiety, low mood, or significant sleep disruption, CBT provides a meaningful complement to or alternative for HRT.

Vaginal oestrogen is a topical treatment that acts locally with very low systemic absorption. It can address vaginal dryness, discomfort, and urinary symptoms effectively, and is often suitable for women who have concerns about systemic HRT. A specialist can advise whether it is appropriate.

Lifestyle support, including nutrition focused on bone and cardiovascular health, weight bearing exercise to support bone density, and good sleep habits, forms a practical complement to any treatment plan.

Additionally, Lynkeut has recently begun being prescribed for patients who experience vasomotor symptoms but do not/ can not have HRT.

The emotional side of surgical menopause

The physical symptoms of surgical menopause get most of the clinical attention. The emotional experience is less often acknowledged, and for many women it is just as significant.

A hysterectomy, particularly one performed before the age a woman expected to reach natural menopause, can involve grief. Grief around fertility, around a body that has changed without the usual gradual preparation, around an identity that feels disrupted. These feelings are real and they are valid. They are not a sign that something has gone wrong emotionally. They are a natural response to a significant physical transition.

Voy's outcome data, presented at The Menopause Society 2025 (forthcoming in Climacteric), found that 83% of members reported improved mood and emotional symptoms after starting treatment. That figure matters for women who have had surgical menopause, because it shows that the psychological dimension of this transition is not something to simply wait out. It responds to proper care.

Peer support is part of that care. Knowing that other women have navigated this and come through it, and having space to talk about the experience without being told to get on with things, makes a genuine difference.

Getting the right support

Many women who have had a hysterectomy report that post-operative care focused on recovery from surgery, with very little discussion of what comes next for their hormones. If your ovaries were removed and you were discharged without a clear HRT plan, or if you have been managing symptoms without specialist support, that is worth addressing.

A 45 minute consultation with a BMS trained menopause specialist provides the time to understand your surgical history, review your current symptoms, discuss the right HRT formulation for your situation, and establish a monitoring plan. It is a fundamentally different conversation from a standard GP appointment, and for women who have had surgical menopause, that depth of conversation is not a luxury. It is the appropriate standard of care.

Voy's outcome data shows that 88% of members felt more hormonally balanced at three months, compared to 62% of women receiving standard care, and 93% reported an improvement in overall quality of life. Both figures are from data presented at The Menopause Society 2025, forthcoming in Climacteric. They reflect what happens when menopause care is specialist led, properly monitored, and built around the individual rather than a generic post-surgical protocol.